Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-21712

Xla Wt + rmnd5a MO, Pfirrmann T et al. (2015)

Experiment + Assay: Xla Wt + rmnd5a MO + NF35/36-35 and 36 (in situ hybridization)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rmnd5a MO1 rmnd5a.S
rmnd5a.L
 NF stage 2 (2-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 35 and 36 to NF stage 35 and 36  
Expression Phenotypes (1):
decreased amount en2.L expression in eye
Source: fig.3.A.n,o,q
Article: XB-ART-50241, PubMed